Global Cannabinoid Derived Pharmaceutical Market Assessment

Report ID : 1042 | Published : 2021-07-19 | Pages: | Format: PDF/EXCEL

Cannabinoids are naturally occurring compounds derived from the Cannabis sativa plant. In recent years, Cannabinoids/medical marijuana have witnessed increased attention due to its growing therapeutic applications in human medicine. Cannabinoid’s active components are potentially effective in treating a variety of conditions, including chronic pain, cancer pain, depression, anxiety disorders, sleep disturbances, and neurological disorders. The recent upsurge in the use and acceptance of CBD can be principally attributed to the onset of cannabis legalization across the United States. Most recently, the passage of the 2018 Farm Bill, which legalized the cultivation of hemp – cannabis with less than 0.3 percent THC by weight.

The demand for cannabinoid extracts and isolates is expected to grow exponentially in the coming years, on account of the anticipated shift in consumer preferences for derivative cannabis product formats, and the applications for cannabinoids in pharmaceutical applications. The market is also driven by growing awareness about the therapeutic benefits paired with healing properties associated with cannabidiol (CBD). Moreover, cannabidiol (CBD) is widely used in several medical applications such as treatment of anxiety and depression, stress relief, diabetes prevention, mitigation of pain, alleviation of cancer symptoms, and acne reduction. The market is expected to show lucrative opportunities over the forecast period owing to the augmented adoption of CBD-based products for treating various medical conditions.

The global Cannabinoid Derived Pharmaceutical market is segmented on the basis of product, application, and region. Based on the products, the market is divided into Cannabinoid Receptor Type 1 (CB1), Cannabinoid Receptor Type 2 (CB2), and Others. On the basis of application type, the market is segmented into Alzheimer’s Disease, Autism, Cancer, Chronic Pain, Epilepsy, Migraine, Multiple Sclerosis, Schizophrenia, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

The key players of this market include Cara Therapeutics, Inc., Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc., Echo Pharmaceuticals, GW Pharmaceuticals, InMed Pharmaceuticals, INSYS Therapeutics, Inc., LaraPharm, MGC Pharmaceuticals, Ltd., One World Cannabis, Orpheus Medica, Receptor Life Sciences, RespireRx Pharmaceuticals, Tetra Bio-Pharma, Cardiol Therapeutics, United cannabis Corporation, Zynerba Pharmaceuticals, and List of Other Prominent Players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cannabinoid Derived Pharmaceutical Market Snapshot

Chapter 4. Global Cannabinoid Derived Pharmaceutical Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Penetration & Growth Prospect Mapping

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Technology Advancement in Cannabinoid Derived Pharmaceutical

4.9. Key Trends in the Market

Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2028 for the following Product:

5.2.1. Cannabinoid Receptor Type 1 (CB1)

5.2.2. Cannabinoid Receptor Type 2 (CB2)

5.2.3. Others

Chapter 6. Cannabinoid Derived Pharmaceutical Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2019 & 2028

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2028 for the following Application:

6.2.1. Alzheimer’s Disease

6.2.2. Autism

6.2.3. Cancer

6.2.4. Chronic Pain

6.2.5. Epilepsy

6.2.6. Migraine

6.2.7. Multiple Sclerosis

6.2.8. Schizophrenia

6.2.9. Others

Chapter 7. Cannabinoid Derived Pharmaceutical Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) estimates and forecasts by product, 2019-2028

7.1.2. North America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) estimates and forecasts by end-user, 2019-2028

7.1.3. North America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) estimates and forecasts by country, 2019-2028

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by product, 2019-2028

7.2.2. Europe Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by end-user, 2019-2028

7.2.3. Europe Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by country, 2019-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by product, 2019-2028

7.3.2. Asia Pacific Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by end-user, 2019-2028

7.3.3. Asia Pacific Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by country, 2019-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by product, (US$ Million)

7.4.2. Latin America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by end-user, (US$ Million)

7.4.3. Latin America Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA revenue Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by product, (US$ Million) 2019-2028

7.5.2. MEA revenue Cannabinoid Derived Pharmaceutical Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.5.2.1. South Africa

7.5.2.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Arena Pharmaceuticals

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Product portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Cannabics Pharmaceuticals Inc.

8.2.3. Cara Therapeutics, Inc.

8.2.4. Cardiol Therapeutics

8.2.5. Echo Pharmaceuticals

8.2.6. GW Pharmaceuticals

8.2.7. InMed Pharmaceuticals

8.2.8. INSYS Therapeutics, Inc

8.2.9. LaraPharm

8.2.10. MGC Pharmaceuticals, Ltd.

8.2.11. One World Cannabis

8.2.12. Orpheus Medica

8.2.13. Receptor Life Sciences

8.2.14. RespireRx Pharmaceuticals

8.2.15. Tetra Bio-Pharma

8.2.16. United cannabis Corporation

8.2.17. Zynerba Pharmaceuticals

8.2.18. List of Other Prominent Players

Global Cannabinoid Derived Pharmaceutical Market Segmentation

 

Global Cannabinoid Derived Pharmaceutical Market by Product

  • Cannabinoid Receptor Type 1 (CB1)
  • Cannabinoid Receptor Type 2 (CB2)
  • Others

Global Cannabinoid Derived Pharmaceutical Market Based on Application

  • Alzheimer’s Disease
  • Autism
  • Cancer
  • Chronic Pain
  • Epilepsy
  • Migraine
  • Multiple Sclerosis
  • Schizophrenia
  • Others

 

Global Cannabinoid Derived Pharmaceutical Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients